Agustin Melian - Oct 4, 2021 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role
Chief Medical Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Stock symbol
ALVR
Transactions as of
Oct 4, 2021
Transactions value $
-$446,862
Form type
4
Date filed
10/5/2021, 09:05 PM
Previous filing
Sep 29, 2021
Next filing
Jul 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale -$249K -10.7K -2.26% $23.29* 462K Oct 4, 2021 Direct F1, F2
transaction ALVR Common Stock Sale -$114K -4.71K -1.02% $24.23* 457K Oct 4, 2021 Direct F1, F3
transaction ALVR Common Stock Sale -$75.4K -2.97K -0.65% $25.41* 454K Oct 4, 2021 Direct F1, F4
transaction ALVR Common Stock Sale -$8.67K -333 -0.07% $26.02* 454K Oct 4, 2021 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.78 to $23.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.78 to $24.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.78 to $25.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.795 to $26.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.